SEI Investments’s Rhythm Pharmaceuticals RYTM Stock Holding History
Bought
Maintained
Sold
Other funds holding RYTM
RCM
BBA
PA
SEI Investments's RYTM Position: Q2 2026 in Review
SEI Investments reduced its Rhythm Pharmaceuticals (RYTM) stake by 46% in Q2 2026, selling an estimated $1.68M and leaving 22,087 shares worth $2.45M. The position accounts for ﹤0.01% of the portfolio, ranked #1855.
SEI Investments first reported a position in RYTM in Q3 2022 and has held it in 13 quarters since. The position peaked at $4.01M in Q4 2025. 304 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.
- SEI Investments held 22,087 shares of Rhythm Pharmaceuticals worth $2.45M as of Q2 2026.
- SEI Investments sold 18,598 Rhythm Pharmaceuticals shares in Q2 2026, an estimated $1.68M.
- Rhythm Pharmaceuticals made up ﹤0.01% of SEI Investments's portfolio in Q2 2026, its #1855 holding.
- SEI Investments first reported a position in Rhythm Pharmaceuticals in Q3 2022 and has held it in 13 quarters since.
- SEI Investments's Rhythm Pharmaceuticals position peaked at $4.01M in Q4 2025.
- 304 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.
Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.